WO2001000662A3 - Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques - Google Patents
Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques Download PDFInfo
- Publication number
- WO2001000662A3 WO2001000662A3 PCT/US2000/011885 US0011885W WO0100662A3 WO 2001000662 A3 WO2001000662 A3 WO 2001000662A3 US 0011885 W US0011885 W US 0011885W WO 0100662 A3 WO0100662 A3 WO 0100662A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hfgf
- fgh
- polypeptides
- human
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU58666/00A AU5866600A (en) | 1999-06-29 | 2000-06-21 | The use of human fgh-8 polypeptides as neurotrophic agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14154999P | 1999-06-29 | 1999-06-29 | |
US60/141,549 | 1999-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001000662A2 WO2001000662A2 (fr) | 2001-01-04 |
WO2001000662A3 true WO2001000662A3 (fr) | 2001-05-17 |
Family
ID=22496178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/011885 WO2001000662A2 (fr) | 1999-06-29 | 2000-06-21 | Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5866600A (fr) |
WO (1) | WO2001000662A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7414019B2 (en) * | 2002-10-04 | 2008-08-19 | Auckland Uniservices Limited | FGF-8 methods of use |
CA2637707A1 (fr) | 2006-02-02 | 2007-08-09 | Rinat Neuroscience Corporation | Procedes de traitement de l'obesite par administration d'un antagoniste trkb |
EP3104873B1 (fr) | 2014-02-13 | 2019-09-04 | Technische Universität München | Fgf-8 pour son utilisation dans le traitement des maladies ou des troubles de l'homéostasie énergétique |
KR102149321B1 (ko) | 2015-10-31 | 2020-08-28 | 아이오 테라퓨틱스, 인크. | Rxr 아고니스트와 갑상선 호르몬의 조합을 사용한 신경계 질환의 치료 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003199A1 (fr) * | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Procede ameliorant la differentiation et les chances de survie des cellules precurseurs neuronales |
WO1994020125A1 (fr) * | 1993-03-12 | 1994-09-15 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Traitement des affections des neurones moteurs a l'aide du facteur de croissance des fibroblastes 5 (fgf-5) |
-
2000
- 2000-06-21 AU AU58666/00A patent/AU5866600A/en not_active Abandoned
- 2000-06-21 WO PCT/US2000/011885 patent/WO2001000662A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003199A1 (fr) * | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Procede ameliorant la differentiation et les chances de survie des cellules precurseurs neuronales |
WO1994020125A1 (fr) * | 1993-03-12 | 1994-09-15 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Traitement des affections des neurones moteurs a l'aide du facteur de croissance des fibroblastes 5 (fgf-5) |
Non-Patent Citations (2)
Title |
---|
MARK ROBERT J ET AL: "Fibroblast growth factor-8 protects cultured rat hippocampal neurons from oxidative insult.", BRAIN RESEARCH, vol. 830, no. 1, 29 May 1999 (1999-05-29), pages 88 - 93, XP000979185, ISSN: 0006-8993 * |
WAGLE A P ET AL: "Basic fibroblast growth factor protects neuronal SH-SY5Y cells from nitric oxide mediated apoptosis and stimulates neurite outgrowth.", FASEB JOURNAL, vol. 13, no. 4 PART 1, 12 March 1999 (1999-03-12), Annual Meeting of the Professional Research Scientists for Experimental Biology 99;Washington, D.C., USA; April 17-21, 1999, pages A387, XP002158587, ISSN: 0892-6638 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001000662A2 (fr) | 2001-01-04 |
AU5866600A (en) | 2001-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1276756A1 (fr) | Proteines de fusion d'albumine | |
WO2003060071A3 (fr) | Proteines hybrides d'albumine | |
WO1999038972A9 (fr) | Genes humains et produits ii d'expression genique | |
WO2002024909A3 (fr) | Acides nucleiques et polypeptides de nouveau recepteur | |
WO1999058675A3 (fr) | Genes humains et produits d'expression genique v | |
WO1999033982A3 (fr) | Genes humains et produits d'expression genique i | |
EP1005540A4 (fr) | Proteines ikk-beta, acides nucleiques et procedes | |
WO2001070977A3 (fr) | Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations | |
WO2001036432A3 (fr) | 18 proteines secretees humaines | |
WO2001032910A3 (fr) | 27 proteines humaines secretees | |
WO2003030821A3 (fr) | Proteines de fusion d'albumine | |
WO1998014596A3 (fr) | Tyrosine phosphatases proteiques associees a des maladies | |
WO2001012776A3 (fr) | 18 proteines secretees humaines | |
WO2001034768A3 (fr) | 15 proteines secretees humaines | |
WO1998011234A3 (fr) | Proteines kinases humaines | |
WO2000052136A3 (fr) | Enzymes de glycosylation humaines | |
WO2000077026A8 (fr) | 49 proteines secretees humaines | |
WO2001042474A3 (fr) | Molecules de type interferon et utilisations | |
WO2000063230A3 (fr) | 49 proteines secretees humaines | |
WO2001062891A3 (fr) | 207 proteines humaines secretees | |
WO2001000662A3 (fr) | Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques | |
WO2000059942A3 (fr) | COMPOSITIONS hOB-BP2h, LEURS TECHNIQUES ET LEURS UTILISATIONS | |
WO2001059120A3 (fr) | Molecules de type il-17 et utilisation de ces dernieres | |
WO2000058339A3 (fr) | 50 proteines humaines secretees | |
WO1997002730A3 (fr) | Polypeptide associe a une matrice d'email |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |